SMPD1 and Parkinson disease: A founder mutation (p.L304P) in the lysosomal gene sphingomyelin phosphodiesterase 1 (SMPD1), which encodes ASMase, can lead to abnormalities in the lysosome functions with disruption in α-Syn clearance and an increased risk for PD [120].